carbapenems - CISMeF

Preferred Label : carbapenems;

MeSH definition : A group of beta-lactam antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom. THIENAMYCINS are a subgroup of carbapenems which have a sulfur atom as the first constituent of the side chain.;

MeSH synonym : carbapenem antibiotics; antibiotics, carbapenem; Carbapenem;

Wikipedia link : https://en.wikipedia.org/wiki/Carbapenems;

Is substance : O;

Details

Origin ID

D015780;

UMLS CUI

C0006968;

ATC code(s)
- carbapenems [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Carbapenems [ICD-11 Extension code]
Currated CISMeF NLP mapping
- Carbapenem (substance) [SNOMED CT concept]
- Lenapenem [NCIt concept]
Indexing information
- L 786392 [MeSH Supplementary Concept]
Record concept(s)
- carbapenems [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1 beta-methylcarbapenem [MeSH Supplementary Concept]
- 1-aza-6-(1-hydroxyethyl)-4-methyl-7-oxo-3-(((2-(1,2,3-thiadiazol-5-yl)thiomethyl)pyrrolidin-4-yl)thio)bicyclo(3.2.0)heptane-2-carboxylic acid [MeSH Supplementary Concept]
- 1-carbapen-2-em-3-carboxylic acid [MeSH Supplementary Concept]
- 1-ethylpropyloxycarbonyloxymethyl (1R,5S,6S)-2-((3S,5S)-5-(N,N-dimethylcarbamoyl)-1-(isobutyryloxymethyloxycarbonyl)pyrrolidin-3-ylthio)-6-((1R)-1-hydroxyethyl)-1-methylcarbapen-2-em-3-carboxylate [MeSH Supplementary Concept]
- 2-hydroxymethyl-1-carbapenam [MeSH Supplementary Concept]
- 3-((4-(2,5-dihydro-1H-pyrrol-3-yl)-1,3-thiazol-2-yl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid [MeSH Supplementary Concept]
- 6-(1-hydroxyethyl)-1-methyl-2-((pyrrolidin-3-yl-hydroxymethyl)pyrrolidin-4-ylthio)-1-carbapen-2-em-3-carboxylic acid hydrochloride [MeSH Supplementary Concept]
- 6-(1-hydroxyethyl)-2-(5-chloro-2-oxobenzoxazolin-3-yl)-1-methyl-1-carbapen-2-em-3-carboxylic acid [MeSH Supplementary Concept]
- 6-(1-hydroxyethyl)-3-((4-(2-(hydroxymethyl)-1,2,3,6-tetrahydropyridin-4-yl)-1,3-thiazol-2-yl)thio)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid [MeSH Supplementary Concept]
- 6-(1-hydroxyethyl)-4-methyl-3-((4-(2-methyl-1,2,3,6-tetrahydropyridin-4-yl)-1,3-thiazol-2-yl)thio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid [MeSH Supplementary Concept]
- BMS 181139 [MeSH Supplementary Concept]
- BO 2727 [MeSH Supplementary Concept]
- BO 3482 [MeSH Supplementary Concept]
- CL 191121 [MeSH Supplementary Concept]
- CP0569 [MeSH Supplementary Concept]
- CP5484 [MeSH Supplementary Concept]
- CS 834 [MeSH Supplementary Concept]
- CW-270033 [MeSH Supplementary Concept]
- DA 1131 [MeSH Supplementary Concept]
- DK 35C [MeSH Supplementary Concept]
- DU 6681 [MeSH Supplementary Concept]
- DX 8739 [MeSH Supplementary Concept]
- DZ 2640 [MeSH Supplementary Concept]
- E1010 [MeSH Supplementary Concept]
- FCE 25199 [MeSH Supplementary Concept]
- J 111225 [MeSH Supplementary Concept]
- J 111347 [MeSH Supplementary Concept]
- J 114870 [MeSH Supplementary Concept]
- KR 21012 [MeSH Supplementary Concept]
- L 084 [MeSH Supplementary Concept]
- L 695256 [MeSH Supplementary Concept]
- L 749345 [MeSH Supplementary Concept]
- LJC 11036 [MeSH Supplementary Concept]
- LK-157 [MeSH Supplementary Concept]
- ME1036 [MeSH Supplementary Concept]
- MK 826 [MeSH Supplementary Concept]
- OCA-983 [MeSH Supplementary Concept]
- PGE-5428060 [MeSH Supplementary Concept]
- R 95867 [MeSH Supplementary Concept]
- SM 17466 [MeSH Supplementary Concept]
- SM-216601 [MeSH Supplementary Concept]
- SUN 5555 [MeSH Supplementary Concept]
- TA 949 [MeSH Supplementary Concept]
- benapenem [MeSH Supplementary Concept]
- beta-methyl ADC-13 enolphosphate diphenyl ester [MeSH Supplementary Concept]
- carbapenem-3-carboxylic acid [MeSH Supplementary Concept]
- pivaloyloxymethyl(1R,5S,6S)-2-((3S,5S)-5-(N,N-dimethylcarbamoyl)-1-(isobutyryloxymethyloxycarbonyl)pyrrolidin-3-ylthio)-6-((1R)-1-hydroxyethyl)-1-methylcarbapen-2-em-3-carboxylate [MeSH Supplementary Concept]
- pluracidomycin [MeSH Supplementary Concept]
- ritipenem [MeSH Supplementary Concept]
- tebipenem [MeSH Supplementary Concept]
- tomopenem [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Product containing carbapenem (product) [SNOMED CT concept]
Semantic type(s)
- Antibiotic [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Carbapenem [LOINC component]
- Carbapenem (substance) [SNOMED CT concept]
- Lenapenem [NCIt concept]
- Product containing carbapenem (product) [SNOMED CT concept]
- carbapenems [ATC Code]
Validated automatic mappings to BTNT
- Carbapenem [LOINC component]
- carbapenems [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients